Markets:

Overview

News

Currencies

International

Treasuries

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

4.223 +2.403 (+132.01%)

Streaming Delayed Price Updated: 12:55 PM EDT, Apr 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Research

Quarterly Reports Insider Filings Other Filings

All News about Enveric Biosciences, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 11, 2022

Via Benzinga

EXCLUSIVE: NASDAQ-Listed Enveric To Split Into Two Companies, One For Cannabinoids, One For Psychedelics ↗

May 11, 2022

Enveric Biosciences (NASDAQ: ENVB), a biotech company working with cannabinoids and psychedelics, announced it will spin off its cannabinoid pipeline into a separate public company that will also be...

Via Benzinga

American Billionaire Entrepreneurs Bet Millions on Psychedelics

May 10, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – May 10, 2022 – Billionaire Bob Parsons, the founder of GoDaddy, believes psychedelics can heal trauma. The Marine infantryman...

Via FinancialNewsMedia

Enveric Biosciences Reports Full-Year 2021 Financial Results ↗

April 01, 2022

Via Benzinga

Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved ↗

April 25, 2022

Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami...

Via Benzinga

Missed The Benzinga Psychedelics Capital Conference? Check Out Full Recording And Exclusive Coverage ↗

April 25, 2022

Via Benzinga

Roth Capital Reveals Top Psychedelic Picks in New Industry Report

April 21, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 21, 2022 – Investment banks are continuing to release positive coverage for psychedelic stocks and the latest report...

Via FinancialNewsMedia

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

April 20, 2022

Another day of trading is waiting for investors and we're kicking it off with a look at the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 19, 2022

Gainers

Via Benzinga

EXCLUSIVE: Enveric Offers Investors Rare Exposure To Both Cannabis And Psychedelic Industries ↗

April 19, 2022

There were more than 30 different companies in the psychedelic space present at the inaugural Benzinga Psychedelics Capital Conference on Tuesday. But, Enveric is one of the only ones that offer...

Via Benzinga

21 Stocks Moving in Monday's Pre-Market Session ↗

April 18, 2022

Gainers Mullen Automotive, Inc. (NASDAQ: MULN) shares rose 16.2% to $2.51 in pre-market trading. Mullen Automotive announced plans to begin construction for EV battery pack...

Via Benzinga

Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More! ↗

April 06, 2022

It’s earnings week in the psychedelics space, opening a new window into the financial situations of many companies in the sector.

Via Benzinga

Are Psychedelics Stocks In Trouble Or Is The Market Reaching Maturity? ↗

April 04, 2022

Long gone is the heyday of investor enthusiasm and easy access to capital that marked the launch of the psychedelics industry into the public markets. In recent months, psychedelics stocks entered into...

Via Benzinga

New Research Reveals How Psychedelics Are Helping Combat Mental Illness

March 29, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 29, 2022 – Mental health cases are continuing to rise and are taking a serious toll on the healthcare system. Luckily,...

Via FinancialNewsMedia

Five Companies Developing Second Generation Psychedelics For Mental Health ↗

March 24, 2022

Along with the psychedelic renaissance came a new type of drug: second generation psychedelics. Developed from classic psychedelics ...

Via Benzinga

58 Biggest Movers From Yesterday ↗

March 24, 2022

Gainers Allego N.V. (NYSE: ALLG) shares surged 114.1% to close at $17.73 on Wednesday after the company announced the completion of its merger agreement with Spartan Acquisition...

Via Benzinga

Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory Council ↗

March 09, 2022

DETROIT, March 4, 2022 /PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the ...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022 ↗

March 08, 2022

Upgrades According to Janney Montgomery Scott, the prior rating for Wintrust Financial Corp (NASDAQ:WTFC) was changed from Neutral to Buy. Wintrust Finl earned $1.58 in the fourth...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 01, 2022

Gainers Avenue Therapeutics (NASDAQ:ATXI) shares rose 172.1% to $0.92 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 157.8...

Via Benzinga

Psyched: Psilocybin Therapy Effective After One Year, Cybin & Deepak Chopra, Enveric Psilocybin Cancer Study ↗

February 22, 2022

Psilocybin received yet another confirmation of its beneficial effects in the treatment of major depressive disorder, this time, in the long term. ...

Via Benzinga

Psilocybin For Cancer Related Distress: Enveric To Launch Clinical Trial In Partnership With University of Calgary ↗

February 17, 2022

Enveric Biosciences (NASDAQ:ENVB) a neuroscience company d...

Via Benzinga

Enveric Biosciences Closes $10 Million Public Offering ↗

February 16, 2022

Psychedelics-based company Enveric Biosciences (NASDAQ:ENVB

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 11, 2022

Gainers Avenue Therapeutics (NASDAQ:ATXI...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

February 16, 2022

On Wednesday, 115 companies reached new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low...

Via Benzinga

78 Biggest Movers From Friday ↗

February 14, 2022

Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education...

Via Benzinga

Mid-Afternoon Market Update: US Stocks Extend Losses; Dow Tumbles 450 Points ↗

February 11, 2022

US stocks extended losses toward the end of trading session, with the Dow Jones tumbling 450 points on Friday.

Via Benzinga

52 Weeks High And Low Article ↗

February 11, 2022

On Friday, 106 companies reached new 52-week lows. Things to Consider About Today's 52-Week Lows: Air Products & Chemicals (NYSE:APD) is the largest company...

Via Benzinga

Mid-Day Market Update: Nasdaq Drops 100 Points; Bloom Energy Shares Jump ↗

February 11, 2022

The Nasdaq turned lower during the mid-day session, with the tech-laden index falling 100 points on Friday.

Via Benzinga

41 Stocks Moving In Friday's Mid-Day Session ↗

February 11, 2022

Gainers Modular Medical, Inc. (NASDAQ: MODD) shares climbed 34.5% to $4.99 following its recent uplisting to the Nasdaq Capital Market on Thursday. Kaival Brands Innovations...

Via Benzinga

Enveric Biosciences Shares Fall After $10M Equity Raise ↗

February 11, 2022

Enveric Biosciences Inc (NASDAQ: ENVB) has priced its previously announced underwritten public offering of 20 million shares and warrants to purchase up to 20 million shares...

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Browse News Releases

News Releases Overview

Multimedia Gallery

Multimedia Gallery Overview

Trending Topics

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

All News about Enveric Biosciences, Inc. - Common Stock